$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

대만 건강보험청구데이터(NHIRD)를 이용한 전통 동아시아 의학(TEAM) 임상연구의 현황
Current Status of Clinical Study on Traditional East Asian Medicine Using Taiwan Health Insurance Claim Data 원문보기

Journal of Korean Medicine Rehabilitation : JKMR = 한방재활의학과학회지, v.27 no.2, 2017년, pp.67 - 75  

정창운 (대한한의사협회 한의학정책연구원) ,  조희근 (청연의학연구소) ,  설재욱 (청연한방병원)

Abstract AI-Helper 아이콘AI-Helper

Objectives The study of the clinical effects of traditional east asian medicine (TEAM) using Taiwan national health insurance claim dataset (NHIRD) is useful in Korean Medicine research. We reviewed the clinical studies of TEAM using NHIRD as a whole through this study. Methods We comprehensively se...

주제어

AI 본문요약
AI-Helper 아이콘 AI-Helper

문제 정의

  • 저자들은 상기와 같은 문제의식을 갖고 대만에서 지금 까지 수행된 건강보험기반 TEAM 연구중 한의약 중재의 임상효과를 주제로 하여 이의 효과를 관찰한 연구를 주로 수집, 분석하였다. 또한 분석의 결과를 요약함으로써 국내 한의약 임상의료 및 한의약 정책수립에서의 의사결정의 기반자료로 활용할 수 있도록 소개하려는 목적으로 본 연구를 진행하였다.
본문요약 정보가 도움이 되었나요?

질의응답

핵심어 질문 논문에서 추출한 답변
국내의 건강보험 데이터베이스와 대만의 데이터베이스의 차이는? 한편, 국내와 유사한 전국민건강보험 의료관리체계를 두고 있는 대만에서는 국내보다 앞선 2003년이래 전 민건강보험연구자료고(全民健康保險硏究資料庫, National Health Insurance Research Database)라는 이름의 데이터 베이스를 민간에 제공해왔으며, 이를 활용한 연구는 2015년 6월 1일 현재 2,638편이 발표되어 있을만큼10) 연구에서 중요 정보원으로서 가치가 인정되고 있다11). 특히, 국내의 건강보험 데이터베이스와는 달리 대만의 데이터베이스는 대만 진료환경에서의 개별적 한약 처방내역까지 수록되어 있어, 전통의학 연구를 위한 데이터베이스로서 큰 가치를 가지고 있다. 이와 동시에 대만의 전통의학 임상에서는 고전에 기반한 유명 처방들이 대거 건강보험 보장12)이 이뤄지고 있어, 국내 한의약 현실과의 적합성이 상대적으로 높게 기대된다는 강점이 기대된다.
데이터베이스를 활용한 연구를 국내 한의학 연구에 사용할 전략은? 이러한 결과물들은 국내에서의 보건의료 분야의 주요 질환과 관련된 정책의사결정시 한국 한의약이 기여 할 수 있는 가능성을 빅데이터 방법론을 동원한 연구를 통해서도 보다 세심하게 검토할 필요가 있다는 점을 시사 한다. 다만, 제한적인 수준의 국내 한의약 국내 건강보험 공단 자료의 실정을 고려할 때 국내에서는 별개의 코호트 구축을 통한 한의약 빅데이터 연구가 보다 효율적인 전략이 될 수 있을 것이다.
대만에서 제공중인 데이터베이스는? 한편, 국내와 유사한 전국민건강보험 의료관리체계를 두고 있는 대만에서는 국내보다 앞선 2003년이래 전 민건강보험연구자료고(全民健康保險硏究資料庫, National Health Insurance Research Database)라는 이름의 데이터 베이스를 민간에 제공해왔으며, 이를 활용한 연구는 2015년 6월 1일 현재 2,638편이 발표되어 있을만큼10) 연구에서 중요 정보원으로서 가치가 인정되고 있다11). 특히, 국내의 건강보험 데이터베이스와는 달리 대만의 데이터베이스는 대만 진료환경에서의 개별적 한약 처방내역까지 수록되어 있어, 전통의학 연구를 위한 데이터베이스로서 큰 가치를 가지고 있다.
질의응답 정보가 도움이 되었나요?

참고문헌 (57)

  1. Frankovich J, Longhurst CA, Sutherland SM. Evidencebased medicine in the EMR era. N Engl J Med. 2011;365(19):1758-9. 

  2. The Asahi Shimbun. Big data shows promise in helping cancer patients at Todai. Online document at: http://www.asahi.com/ajw/articles/AJ201609190064.html Accessed March 10, 2017. 

  3. Gulshan V, Peng L, Coram M, et al. Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs. JAMA. 2016;316(22):2402-10. 

  4. Government 3.0 open data portal. Online document at: https://www.data.go.kr/ Accessed March 1, 2017. 

  5. Park DW, Ko MJ et al. A Comparative Study on the Uses of statin and the Risk of diabetes mellituys. Seoul:Natioanl Evidence Based Healthcare Collaborating Agency, 2015. 

  6. Korean Food and Drug Administration. Case announcement of medication - adverse reactions and relationship analysis cases using the drug side effects of medication and health care information. Online document at: http://www.mfds.go.kr/index.do?mid675&pageNo1&seq31342&cmdv Accessed March 3, 2017. 

  7. National Development Institute of Korean Medicine. Symposium on Clinical Informatization of Korean Medicine using Big Data. Seoul:National Development Institute of Korean Medicine, 2016. 

  8. Jung BY, Bae SJ, Jung CW et al. Use of Western Medicine and Traditional Medicine for Joint disorders: Retrospective Comparative Analysis Based on Korean National wide Insurance Data. Seoul:Research Institute of Korean Medicine Policy, The Association of Korean Medicine. 2016. 

  9. Kim KH, Jang SB, Sung JW, et al. A Review on studies of Korean Medicine using secondary data. Journal of Society of Preventive Korean Medicine. 2016;20(1):29-42. 

  10. Natiaonal Health Insurance Research Database. Online document at: http://nhird.nhri.org.tw/file_talk/NHIRD_ PubMed_20150525.xlsx Accessed January 17, 2017. 

  11. Hsing AW, Ioannidis JP. Nationwide Population Science: Lessons From the Taiwan National Health Insurance Research Database. JAMA Intern Med. 2015;175(9):1527-9. 

  12. Kim YK. A Study on the Reasonable Improvement Plan of the Medicines Control Guideline report, Seoul:Health Insurance Review & Assessment Service. 2014. 

  13. Natiaonal Health Insurance Research Database. Online document at: http://nhird.nhri.org.tw/ Accessed January 12, 2017. 

  14. Su SY, Muo CH, Morisky DE. Use of chinese medicine and subsequent surgery in women with uterine fibroid: a retrospective cohort study. Evid Based Complement Alternat Med. 2012;2012:617918. 

  15. Liao YH, Lin JG, Lin CC, et al. Distributions of usage and the costs of conventional medicine and traditional chinese medicine for lung cancer patients in taiwan. Evid Based Complement Alternat Med. 2013;2013:984876. 

  16. Shih CC, Lee HH, Chen TL, et al. Reduced use of emergency care and hospitalization in patients with traumatic brain injury receiving acupuncture treatment. Evid Based Complement Alternat Med. 2013;2013:262039. 

  17. Lee KH, Tsai YT, Lai JN, et al. Concurrent Use of Hypnotic Drugs and Chinese Herbal Medicine Therapies among Taiwanese Adults with Insomnia Symptoms: A Population-Based Study. Evid Based Complement Alternat Med. 2013;2013:987862. 

  18. Chiu HE, Hung YC, Chang KC, et al. Favorable circulatory system outcomes as adjuvant traditional Chinese medicine (TCM) treatment for cerebrovascular diseases in Taiwan. PLoS One. 2014;9(1):e86351. 

  19. Lee YW, Chen TL, Shih YR, et al. Adjunctive traditional Chinese medicine therapy improves survival in patients with advanced breast cancer: a population-based study. Cancer. 2014;120(9):1338-44. 

  20. Hsieh CF, Huang SL, Chen CL, et al. Non-aristolochic acid prescribed Chinese herbal medicines and the risk of mortality in patients with chronic kidney disease: results from a population-based follow-up study. BMJ Open. 2014;4(2):e004033. 

  21. Shih CC, Hsu YT, Wang HH, et al. Decreased risk of stroke in patients with traumatic brain injury receiving acupuncture treatment: a population-based retrospective cohort study. PLoS One. 2014;9(2):e89208. 

  22. Tsai YT, Lai JN, Wu CT. The use of Chinese herbal products and its influence on tamoxifen induced endometrial cancer risk among female breast cancer patients: a population-based study. J Ethnopharmacol. 2014;155(2):1256-62. 

  23. Su SY, Muo CH, Sung FC, et al. Reduction of surgery rate in endometriosis patients who take Chinese medicine: a population-based retrospective cohort study. Complement Ther Med. 2014;22(4):632-9. 

  24. Hsu PC, Tsai YT, Lai JN, et al. Integrating traditional Chinese medicine healthcare into diabetes care by reducing the risk of developing kidney failure among type 2 diabetic patients: a population-based case control study. J Ethnopharmacol. 2014;156:358-64. 

  25. Hung YC, Hung IL, Sun MF, et al. Integrated traditional Chinese medicine for childhood asthma in Taiwan: a Nationwide cohort study. BMC Complement Altern Med. 2014;14:389. 

  26. Chen HY, Lin YH, Wu JC, et al. Use of traditional Chinese medicine reduces exposure to corticosteroid among atopic dermatitis children: a 1-year follow-up cohort study. J Ethnopharmacol. 2015;159:189-96. 

  27. Wu CT, Lai JN, Tsai YT. The prescription pattern of Chinese herbal products that contain dang-qui and risk of endometrial cancer among tamoxifen-treated female breast cancer survivors in Taiwan: a population-based study. PLoS One. 2014;9(12):e113887. 

  28. Yen HR, Sun MF, Lin CL, Sung FC, Wang CC, Liang KL. Adjunctive traditional Chinese medicine therapy for patients with chronic rhinosinusitis: a population-based study. Int Forum Allergy Rhinol. 2015;5(3):240-6. 

  29. Hsu WL, Tsai YT, Wu CT, et al. The Prescription Pattern of Chinese Herbal Products Containing Ginseng among Tamoxifen-Treated Female Breast Cancer Survivors in Taiwan: A Population-Based Study. Evid Based Complement Alternat Med. 2015;2015:385204. 

  30. Lin HC, Lin CL, Huang WY, et al. The use of adjunctive traditional Chinese medicine therapy and survival outcome in patients with head and neck cancer: a nationwide population-based cohort study. QJM. 2015;108(12):959-65. 

  31. Liao YH, Lin CC, Lai HC, et al. Adjunctive traditional chinese medicine therapy improves survival of liver cancer patients. Liver Int. 2015;35(12):2595-602. 

  32. Hu YC, Wu CT, Lai JN, et al. Detection of a negative correlation between prescription of Chinese herbal products containing coumestrol, genistein or daidzein and risk of subsequent endometrial cancer among tamoxifen-treated female breast cancer survivors in Taiwan between 1998 and 2008: A population-based study. J Ethnopharmacol. 2015;169:356-62. 

  33. Lin MY, Chiu YW, Chang JS, et al. Association of prescribed Chinese herbal medicine use with risk of end-stage renal disease in patients with chronic kidney disease. Kidney Int. 2015;88(6):1365-73. 

  34. Tsai DS, Huang MH, Chang YS, et al. The use of Chinese herbal medicines associated with reduced mortality in chronic hepatitis B patients receiving lamivudine treatment. J Ethnopharmacol. 2015;174:161-7. 

  35. Chuang SF, Shih CC, Yeh CC, et al. Decreased risk of acute myocardial infarction in stroke patients receiving acupuncture treatment: a nationwide matched retrospective cohort study. BMC Complement Altern Med. 2015;15:318. 

  36. Shih CC, Liao CC, Sun MF, et al. A Retrospective Cohort Study Comparing Stroke Recurrence Rate in Ischemic Stroke Patients With and Without Acupuncture Treatment. Medicine (Baltimore). 2015;94(39):e1572. 

  37. Lin YJ, Ho TJ, Yeh YC, et al. Chinese Herbal Medicine Treatment Improves the Overall Survival Rate of Individuals with Hypertension among Type 2 Diabetes Patients and Modulates In Vitro Smooth Muscle Cell Contractility. PLoS One. 2015;10(12):e0145109. 

  38. Ma YC, Lin CC, Li CI, et al. Traditional Chinese medicine therapy improves the survival of systemic lupus erythematosus patients. Semin Arthritis Rheum. 2016 Apr;45(5):596-603. 

  39. Chang CC, Chen TL, Chiu HE, et al. Outcomes after stroke in patients receiving adjuvant therapy with traditional Chinese medicine: A nationwide matched interventional cohort study. J Ethnopharmacol. 2016;177:46-52. 

  40. Fleischer T, Chang TT, Chiang JH, et al. Adjunctive Chinese Herbal Medicine therapy improves survival of patients with chronic myeloid leukemia: a nationwide population-based cohort study. Cancer Med. 2016;5(4):640-8. 

  41. Lee AL, Chen BC, Mou CH, et al. Association of Traditional Chinese Medicine Therapy and the Risk of Vascular Complications in Patients With Type II Diabetes Mellitus: A Nationwide, Retrospective, Taiwanese-Registry, Cohort Study. Medicine (Baltimore). 2016;95(3):e2536. 

  42. Tsai TY, Li CY, Livneh H, et al. Decreased risk of stroke in patients receiving traditional Chinese medicine for vertigo: A population-based cohort study. J Ethnopharmacol. 2016;184:138-43. 

  43. Chuang SF, Liao CC, Yeh CC, et al. Reduced risk of stroke in patients with cardiac arrhythmia receiving traditional Chinese medicine: A nationwide matched retrospective cohort study. Complement Ther Med. 2016;25:34-8. 

  44. Chang CC, Lee YC, Lin CC, et al. Characteristics of traditional Chinese medicine usage in patients with stroke in Taiwan: A nationwide population-based study. J Ethnopharmacol. 2016;186:311-21. 

  45. Fleischer T, Chang TT, Chiang JH, et al. Integration of Chinese Herbal Medicine Therapy Improves Survival of Patients With Chronic Lymphocytic Leukemia: A Nationwide Population-Based Cohort Study. Medicine (Baltimore). 2016;95(21):e3788. 

  46. Lien AS, Jiang YD, Mou CH, et al. Integrative traditional Chinese medicine therapy reduces the risk of diabetic ketoacidosis in patients with type 1 diabetes mellitus. J Ethnopharmacol. 2016 Sep 15;191:324-30. 

  47. Weng SW, Liao CC, Yeh CC, et al. Risk of epilepsy in stroke patients receiving acupuncture treatment: a nationwide retrospective matched-cohort study. BMJ Open. 2016;6(7):e010539. 

  48. Hung YC, Cheng YC, Muo CH, et al. Adjuvant Chinese Herbal Products for Preventing Ischemic Stroke in Patients with Atrial Fibrillation. PLoS One. 2016;11(7):e0159333. 

  49. Liu JM, Lin PH, Hsu RJ, et al. Complementary traditional Chinese medicine therapy improves survival in patients with metastatic prostate cancer. Medicine (Baltimore). 2016;95(31):e4475. 

  50. Fleischer T, Chang TT, Chiang JH, et al. Improved Survival With Integration of Chinese Herbal Medicine Therapy in Patients With Acute Myeloid Leukemia: A Nationwide Population-Based Cohort Study. Integr Cancer Ther. 2016. pii: 1534735416664171. [Epub ahead of print] 

  51. Lin SK, Tsai YT, Lo PC, et al. Traditional Chinese medicine therapy decreases the pneumonia risk in patients with dementia. Medicine (Baltimore). 2016;95(37):e4917. 

  52. Wang YJ, Liao CC, Chen HJ, et al. The Effectiveness of Traditional Chinese Medicine in Treating Patients with Leukemia. Evid Based Complement Alternat Med. 2016;2016:8394850. 

  53. Chang CM, Wu PC, Chiang JH, et al. Integrative therapy decreases the risk of lupus nephritis in patients with systemic lupus erythematosus: A population-based retrospective cohort study. J Ethnopharmacol. 2017;196:201-12. 

  54. Wu YT, Lee HY. National Health Insurance database in Taiwan: A resource orobstacle for health research? Eur J Intern Med. 2016;31:e9-e10. 

  55. The Wall street Journal. IBM works on China's Medical Records. Online document at: http://www.wsj.com/articles/SB10001424052748703369704575462653035645256 Accessed March 15, 2017. 

  56. Staa TP, Goldacre B, Gulliford M, et al. Pragmatic randomised trials using routine electronic health records: putting them to the test. BMJ. 2012;344:e55. 

  57. Kim JY, Back YH, Lee SW, et al. Review on Cohort Projects in Domestic and Overseas and Establishment of Cohort on Korean Medicine. Journal of Society of Preventive Korean Medicine 2016 ; 20(1) : 65-73. 

저자의 다른 논문 :

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로